Ironwood Pharmaceuticals
IRWD
IRWD
248 hedge funds and large institutions have $1.56B invested in Ironwood Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 78 increasing their positions, 101 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
4.58% less ownership
Funds ownership: 106.92% → 102.33% (-4.6%)
12% less capital invested
Capital invested by funds: $1.77B → $1.56B (-$204M)
23% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 101
Holders
248
Holding in Top 10
1
Calls
$3.54M
Puts
$2.93M
Top Buyers
| 1 | +$33.3M | |
| 2 | +$22.9M | |
| 3 | +$18.1M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.6M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$13M |
Top Sellers
| 1 | -$31.7M | |
| 2 | -$26.2M | |
| 3 | -$16M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$14.3M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$12.5M |